Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell lineTadashi Ashizawa(Shizuoka Cancer Center), Ken Yamaguchi(Shizuoka Cancer Center)International Journal of OncologyMay 12, 201410.3892/ijo.2014.2439Cited by 40SaveCiteExport RISWatch citationsRelated PapersYKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line|Oncology Reports|2014|36<i>In Vivo</i>Antitumor Activity of the PD-1/PD-L1 Inhibitor SCL-1 in Various Mouse Tumor Models|In Vivo|2024|1